Together, three types of bacteria account for over 90 percent of bacterial meningitis: H. influenza type b, meningococcus, and pneumococcus.
These bacteria are transmitted by person-to-person contact through respiratory secretions. Many people carry these bacteria with no serious consequence. (Pneumococcus, for instance, is the most common cause of ear infections.) A few people get very sick. Pneumococcus causes meningitis in about 3 per 100,000 people. (Textbook of Pediatric Infectious Disease, Saunders 1998)
Sudden onset meningitis features shock, internal bleeding, purple spots, and reduced consciousness at the very outset, with a rapidly progressive course often resulting in death within 24 hours.
More commonly, meningitis begins with several days of upper respiratory symptoms or gastrointestinal symptoms. Most children have high fevers, severe headaches, and poor feeding. They may also have muscle aches, nasal congestion, vomiting, neck stiffness, and seizures.
Children with meningitis become increasingly irritable and/or lethargic. The presence of petechiae (purple spots that indicate internal bleeding) is a sign that the infection may be raging out of control.
Pneumococcal meningitis is a devastating disease. Of all causes of meningitis, it is the most likely to have a negative outcome (Pediatric Infectious Disease Journal, May 1993). The overuse of antibiotics is resulting in increasingly resistant strains of pneumococcus every month.
In 1991, a vaccine against the H. influenzae Type b (HIB) bacteria was incorporated into the routine immunization schedule beginning at 2 months of age. The amount of meningitis plummeted. Arkansas Children's Hospital had about 27 cases of HIB meningitis per year in the 1980's before the vaccine was used. By 1993, the number had dropped to only 1.7 per year (Southern Medical Journal, Jan 1994). During the same period the number of cases dropped by 95 percent in the United States as a whole (Textbook of Pediatric Infectious Diseases, Saunders 1998).
The new pneumococcal vaccine for infants is now FDA approved and recommended by the American Academy of Pediatrics for all children less than 2 years of age. Vaccination of children between 2 and 5 years of age may also be considered on an individual basis. In large clinical studies, the vaccine has been shown to decrease the risk of invasive pneumococcal infection (i.e. meningitis and blood infections) by more than 93%. It has also been shown to decrease the risk of pneumonia and otitis media (ear infections). More information about the vaccine can be found at www.cdc.gov/.
Mercury, a potent toxic metal that targets the developing brain and nervous system, is challenging lead as the number one environmental health threat to American children. According to the EPA's top mercury scientist, one out of every six children born in the United States is exposed to levels of methyl mercury during pregnancy that exceed what the Agency considers safe (Mahaffey 2004). The principal source of high fetal methyl mercury exposure is maternal consumption of contaminated seafood, primarily canned tuna. Pregnant women who eat significant quantities of large ocean-going fish could expose their babies to amounts of mercury that are well above the government's recommended safe levels.
In March, 2004, the Food and Drug Administration revised their mercury seafood advisory to include a specific warning about consumption of canned albacore tuna. Pregnant women and children are advised to eat no more than one six ounce can of albacore tuna per week. The advisory, however, provides no consumption advice for a number of fish where high mercury levels are a concern, including tuna steaks, sea bass, halibut, and many others. The Environmental Working Group has filed a legal challenge to the FDA mercury seafood advisory, charging that it is not based on the best available science on seafood contamination and mercury risk levels to the developing fetus.
But contaminated seafood is not the only source of mercury exposure for the developing fetus or infant. Mercury amalgam dental fillings are a potentially significant source of fetal mercury exposure, although precise amounts are not well characterized. And from 1988 through about 2002, children were exposed to significant doses of mercury from birth through six months of age in the form of a mercury-based preservative, thimerosal, used in routine childhood immunizations. Children born to Rh negative mothers were also exposed to mercury in-utero when their mothers received a mercury-containing RhoGAM shot. The flu shot is another source of fetal and infant mercury exposure. The health impact of mercury exposure through vaccinations has been the source of intense debate because of significant changes in the vaccination regimen from 1988 through 1991 that increased neonatal and infant exposure to mercury.
In 1988, the Centers for Disease Control (CDC) recommended important new additions to the nation's infant immunization program, including three Hepatitis B immunizations (one injected at birth), and three Haemophilis B shots—all delivered by six months of age. Drug companies responded with vaccinations supplied in multiple dose containers preserved with the mercury-based antibacterial thimerosal. Neither the CDC, nor the Food and Drug Administration (FDA), which monitors the safety of vaccinations, expressed concerns at that time about the relatively high doses of mercury that newborn babies and infants would be exposed to through these shots.
Drug companies were similarly silent on the matter, although internal company documents show that they were aware of the potent neurotoxic effects of mercury as early as the 1940s. Notably, the FDA banned the sale of topically applied thimerosal antibiotics in the 1980s due to severe, even crippling, adverse skin reactions in sensitive individuals.
The amount of mercury in the standard battery of childhood immunizations more than doubled between 1988 and 1991 when these additional shots were added to the early childhood vaccination regimen. Throughout the 1990s, children received nine mercury-containing vaccinations within their first six months of life, including the unprecedented injection of a mercury-containing vaccine at birth, and up to three shots given in a single day at 2-, 4-, and 6-months. The average two-month old baby vaccinated with thimerosal-containing shots in the 1990s received a single day dose of mercury that was between 100 and 125 times the government's long-term safe exposure level.
Drug companies used thimerosal as a vaccine preservative to allow multiple injections to be shipped and stored in single containers. Thimerosal is 49 percent ethyl mercury, a widely recognized and potent neurotoxin. After more than a decade of nationwide, high childhood exposures, it was removed from childhood vaccinations between 1999 and 2002, at the urging of the Public Health Service and the American Academy of Pediatrics, but is still present in most flu vaccines. California and Iowa have banned mercury-containing thimerosal from all vaccinations, and Missouri and Nebraska have legislation in progress.
Many children go through a phase of wanting to sleep in their parent’s bed. If you don't choose to have a "family bed", click here for tips to get them back into their own beds.
So should we be concerned about a little boy who wants to be called a girl...
I walked without crawling when I was a kid and I think my daughter is on the...
I'm sure you will check with the baby's pediatrician, but you can also check...
Does she have any friends or cousins who are potty trained? My daughter...